Nimelide (Nimesulide)

Nimesulide, the active ingredient in Nimelide, is a nonsteroidal anti‑inflammatory drug presented as an oral tablet for oral use. It treats mild to moderate pain, fever, and inflammatory conditions such as osteoarthritis and dysmenorrhea in adult patients across the European market.

GNH USA supplies Nimelide as a licensed, GDP‑compliant international pharmaceutical supplier, providing quality‑assured products to hospitals, pharmacies and clinics worldwide. The company adheres to stringent manufacturing standards and supports global procurement processes. Its distribution network ensures timely delivery and regulatory compliance in multiple regions.

Nimesulide is used to manage pain and inflammation associated with several common conditions.

Mild to moderate pain: provides analgesic relief for headaches, dental pain, musculoskeletal discomfort, and similar conditions. Fever: reduces elevated body temperature in acute febrile states. Inflammatory conditions (e.g., osteoarthritis, dysmenorrhea): decreases inflammation and associated symptoms.

Nimesulide may cause a range of adverse reactions, which are categorized by frequency and severity.

Common Side Effects: - Gastrointestinal discomfort: mild nausea, dyspepsia, or abdominal pain. - Headache: transient mild to moderate headache episodes. - Dizziness: occasional light‑headedness or vertigo. - Skin rash: mild erythematous eruptions.

Serious or Rare Side Effects: - Hepatotoxicity: elevated liver enzymes or severe liver injury. - Severe skin reactions: Stevens‑Johnson syndrome or toxic epidermal necrolysis. - Renal impairment: acute kidney injury, especially with dehydration. - Anaphylaxis or severe allergic reactions: bronchospasm, angioedema, or shock. - Cardiovascular events: increased risk of thrombotic events in susceptible patients. - Blood dyscrasias: agranulocytosis or thrombocytopenia.

Before prescribing Nimesulide, clinicians should evaluate patient‑specific risk factors and monitor for potential complications.

Assess liver function: obtain baseline hepatic enzymes before initiating therapy. Avoid in patients with known hypersensitivity to NSAIDs: discontinue if allergic reactions occur. Use lowest effective dose for shortest duration: limit exposure to reduce adverse event risk. Monitor renal function in patients with pre‑existing kidney disease: adjust therapy as needed. Avoid concomitant use with other COX‑2 inhibitors or high‑dose aspirin: additive toxicity may occur. Store at ambient temperature below 25°C: keep in the original pack, protect from moisture and direct sunlight.

Nimesulide can interact with several drug classes, requiring careful assessment.

Major Interactions (Avoid): - Concurrent use with anticoagulants (e.g., warfarin): increased bleeding risk. - Combination with other NSAIDs or COX‑2 inhibitors: additive gastrointestinal toxicity. - Use with hepatotoxic drugs (e.g., isoniazid, methotrexate): heightened liver injury risk.

Moderate Interactions (Monitor Closely): - Concomitant use with diuretics or ACE inhibitors: possible renal function changes. - Co‑administration with lithium: monitor lithium serum levels. - Interaction with oral hypoglycemics: may affect glucose control. - Use with corticosteroids: increased risk of gastrointestinal ulceration.